Skip to content
10-Q

Quarterly Report

NEUMORA THERAPEUTICS, INC. NMRA

0001193125-25-269446

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 167.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 161.84M sh
Shares Diluted Q3 2025 · Sep 30, 2025 161.66M sh
Shares Diluted Q3 2025 · Sep 30, 2024 159.58M sh
Shares Diluted Q3 2025 · Sep 30, 2024 158.84M sh
Capex Q3 2025 · Sep 30, 2025 $16K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$158.49M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$132.6M
Long Term Debt Q3 2025 · Sep 30, 2025 $19.56M
Long Term Debt Q3 2025 · Dec 31, 2024 $0
Short Term Debt Q3 2025 · Sep 30, 2025 $20M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $129.07M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $142.15M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $275.71M
Stockholders Equity Q3 2025 · Sep 30, 2025 $132.16M
Stockholders Equity Q3 2025 · Jun 30, 2025 $182.88M
Stockholders Equity Q3 2025 · Mar 31, 2025 $228.36M
Stockholders Equity Q3 2025 · Dec 31, 2024 $287.06M
Stockholders Equity Q3 2025 · Sep 30, 2024 $320.74M
Stockholders Equity Q3 2025 · Jun 30, 2024 $381.26M
Stockholders Equity Q3 2025 · Mar 31, 2024 $424.54M
Stockholders Equity Q3 2025 · Dec 31, 2023 $469.08M
Current Liabilities Q3 2025 · Sep 30, 2025 $25.84M
Current Liabilities Q3 2025 · Dec 31, 2024 $29.89M
Total Liabilities Q3 2025 · Sep 30, 2025 $45.67M
Total Liabilities Q3 2025 · Dec 31, 2024 $29.91M
Current Assets Q3 2025 · Sep 30, 2025 $177.08M
Current Assets Q3 2025 · Dec 31, 2024 $314.06M
Total Assets Q3 2025 · Sep 30, 2025 $177.83M
Total Assets Q3 2025 · Dec 31, 2024 $316.97M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.45
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.16
Eps Basic Q3 2025 · Sep 30, 2025 −$0.35
Eps Basic Q3 2025 · Sep 30, 2025 −$1.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.45
Eps Basic Q3 2025 · Sep 30, 2024 −$1.16
Sga Expense Q3 2025 · Sep 30, 2025 $12.18M
Sga Expense Q3 2025 · Sep 30, 2025 $46.28M
Sga Expense Q3 2025 · Sep 30, 2024 $16.02M
Sga Expense Q3 2025 · Sep 30, 2024 $45.53M
Rd Expense Q3 2025 · Sep 30, 2025 $40.52M
Rd Expense Q3 2025 · Sep 30, 2025 $131.4M
Rd Expense Q3 2025 · Sep 30, 2024 $60.63M
Rd Expense Q3 2025 · Sep 30, 2024 $155.02M
Net Income Q3 2025 · Sep 30, 2025 −$56.76M
Net Income Q3 2025 · Sep 30, 2025 −$177.48M
Net Income Q3 2025 · Jun 30, 2025 −$52.73M
Net Income Q3 2025 · Mar 31, 2025 −$67.99M
Net Income Q3 2025 · Sep 30, 2024 −$72.55M
Net Income Q3 2025 · Sep 30, 2024 −$184.97M
Net Income Q3 2025 · Jun 30, 2024 −$58.7M
Net Income Q3 2025 · Mar 31, 2024 −$53.72M
Operating Income Q3 2025 · Sep 30, 2025 −$57.7M
Operating Income Q3 2025 · Sep 30, 2025 −$182.68M
Operating Income Q3 2025 · Sep 30, 2024 −$76.65M
Operating Income Q3 2025 · Sep 30, 2024 −$200.54M